On Air Now

Current Show

Free Talk Live   9:00 PM - 12:00 AM

Call Free Talk Live now at 1-855-450-FREE

Show Info »

Upcoming Shows

Program Schedule »

Listen

Listen Live Now » 590 AM Kalamazoo, MI

Weather

Current Conditions(Kalamazoo,MI 49001)

More Weather »
74° Feels Like: 74°
Wind: SSW 6 mph Past 24 hrs - Precip: 0.01”
Current Radar for Zip

Tonight

Scattered Thunderstorms 69°

Tomorrow

Thunderstorms 85°

Sun Night

Scattered Thunderstorms 68°

Alerts

Actelion buys U.S.-based firm with cancer drug in development

A general view shows Swiss biotech group Actelion Headquarters in Allschwil near Basel, April 23, 2011. REUTERS/Christian Hartmann
A general view shows Swiss biotech group Actelion Headquarters in Allschwil near Basel, April 23, 2011. REUTERS/Christian Hartmann

ZURICH (Reuters) - Actelion said it will acquire Ceptaris, a privately held U.S.-based specialty pharmaceutical company developing a topical drug, Valchlor, to treat a form of cancer.

Allschwil-based Actelion said it already paid Ceptaris $25 million and will pay another $225 million when the deal closes. The deal is contingent on Valchlor clinching approval from the U.S. health regulator.

"We expect the transaction to become cash-accretive before the end of 2014," Actelion executive Nicholas Franco said in a statement on Wednesday.

(Reporting By Katharina Bart)

Comments